Eminence Capital, LP Bausch & Lomb Corp Transaction History

Eminence Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$16.03 - $20.07 $3.38 Million - $4.24 Million	-211,134 Reduced 3.78%	5,368,375 $108 Million
Q1 2023 May 15, 2023	BUY	$15.67 - $18.91 $21.5 Million - $25.9 Million	1,372,224 Added 32.62%	5,579,509 $97.1 Million
Q4 2022 Feb 14, 2023	BUY	$13.5 - $17.14 $7.34 Million - $9.32 Million	543,895 Added 14.85%	4,207,285 $65.3 Million
Q3 2022 Nov 14, 2022	BUY	$14.23 - $17.76 $12.5 Million - $15.5 Million	875,559 Added 31.41%	3,663,390 $56.2 Million
Q2 2022 Aug 15, 2022	BUY	$13.36 - $20.0 $37.2 Million - $55.8 Million	2,787,831 New	2,787,831 $42.5 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.